Displaying extensive expertise in defending clients within the life sciences, real estate, and financial institution industry sectors, Goodwin is led by the quintet of Caroline Bullerjahn, Deborah Birnbach, Jonathan Shapiro, Daniel Roeser, and Douglas Flaum. Flaum often acts on behalf of domestic and foreign corporations and special board committees, while Roeser supports companies and directors in the fintech and biotechnology industries. Birnbach is particularly well-placed to advise on securities litigations, including class action defense, SEC and internal investigations, fiduciary duty claims, and proxy contests. Bullerjahn offers a wealth of experience when it comes to post-closing disputes, corporate governance matters, and SPAC-related litigation. Morgan Mordecai left the firm in June 2025.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Testimonials
Collated independently by Legal 500 research team.
‘Jonathan Shapiro and Dan Roeser provide excellent analysis and rigorous advocacy. They comprise a diverse team included underrepresented groups and is highly collaborative. ’
‘Jonathan Shapiro is a great lawyer and wonderful collaborator. He is a highly effective and committed advocate who cares deeply about his clients.’
'Partners in the practice are very smart and strategic. They have a terrific touch in working with individual clients in particular, and a deep expertise with underwriters.'
'Dan Roeser is excellent and provides top-notch client service.'
Key clients
- Eaton Vance Senior Independent Trustees
- Fulcrum Therapeutics, Inc.
- Aldeyra Therapeutics, Inc.
- AlloVir, Inc.
- CEO of TuSimple Holdings, Inc./CreateAI
- Christopher Cooper
- Directors and Officers of Silvergate Capital Corporation (Dennis Frank, Rob, Campbell, and Derek Eise)
- True Ventures
- Zuora Board of Directors
- Benchmark Capital
- Arlington Capital Partners V, L.P., Arlington Capital Partners VI, L.P., BlueHalo Financing Topco, LLC, and BlueHalo Holdings Parent, LLC
- Former Officer and Director of Cedar Realty Trust, Inc.
Work highlights
Successful trial-win for the Independent Trustees of certain Eaton Vance closed-end funds in litigation against activist investor Saba Capital, defending bylaw amendments designed to protect the funds and their long-term shareholders.
Secured a complete victory for Fulcrum Therapeutics and its officers in a securities class action arising from the company’s announcement of an FDA clinical hold on its sickle-cell therapy candidate, defeating claims that Fulcrum misled investors about the hold and allegedly inflated its stock price.
Successfully represented former directors of Silvergate Capital Corporation and its wholly owned subsidiary Silvergate Bank in federal securities and related derivative litigation defending claims of misstatements about the Bank’s diligence of digital-asset clients.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Caroline Bullerjahn; Deborah Birnbach; Jonathan Shapiro; Daniel Roeser; Douglas Flaum
Other key lawyers
Adam Slutsky; Nicole L. Chessari; Justin Ward; John Barker; Charles Brown; Brendan Blake; Jordan Benson